Parkinson's disease (PD) is characterized by aggregation of alpha-synuclein (a-synuclein) into """"""""Lewy bodies"""""""" and """"""""Lewy neurites"""""""", and a progressive loss of specific neuronal populations. In particular, ventral midbrain (VM) dopamine (DA) neurons of the substantia nigra (SN) preferentially degenerate in PD, while neighboring ventral tegmental area (VTA) DA neurons are relatively spared. Our previous studies indicate that """"""""multiple hits"""""""", consisting of high cytoplasmic Ca2+, elevated cytosolic DA (DAcyt) and a-synuclein expression are required to evoke selective death of SN dopaminergic neurons and show that interference with any of these three factors rescues the neurons. Here we propose to examine the molecular mechanisms responsible for the toxic interaction between DAcyt, a-synuclein and chaperone-mediated autophagy (CMA), a pathway for selective lysosomal degradation of cytosolic proteins. In particular, we will investigate the possibility that multiple feedback loops between a-synuclein, DA and CMA exacerbate cellular stress and lead to selective degeneration of SN neurons. Previous studies in vitro and on non-neuronal cells suggest that a-synuclein overexpression induces a leakage of neurotransmitter from synaptic vesicles, disrupts stimulation-dependent neurotransmitter release and elevates DAcyt.
In Aim I, we will determine the effect of a- synuclein overexpression or mutation on neuronal DAcyt and quantal DA release. Additionally, we will study the effect of a-synuclein and DAcyt on mitochondrial redox status and neurotoxicity and will assess the specificity of these effects for neurons from SN and locus coeruleus (LC). Next, it has been shown that pathogenic and DA- modified a-synucleins block CMA, which may further increase the level of a-synuclein by preventing its degradation through this pathway.
In Aim II, we will study the synergistic effect of a-synuclein and DAcyt on cellular stress and CMA activity. First, we will determine whether CMA blockade requires a direct interaction between DAcyt and a-synuclein. Second, we will investigate if CMA blockade increases a-synuclein levels, promotes its oligomerization and increases DAcyt. Third, we will study whether enhanced CMA activity rescues cells from DA-a-synuclein-induced toxicity. This project will provide important information about the pathways that lead to differential susceptibility of neuronal populations to stress, which is important for the development of treatments that prevent the death of catecholaminergic neurons in PD.

Public Health Relevance

The aim of this project is to address an essential question in the neuropathology of Parkinson's disease (PD): why are some neuronal populations particularly vulnerable in PD? We hypothesize that the combination of alpha-synuclein overexpression or mutation, Cav1.3 channel-driven pacemaking activity (which enhances cytosolic DA synthesis) and the blockade of chaperon-mediated autophagy underlies selective vulnerability of substantia nigra and locus coeruleus neurons. This study will be important for understanding the mechanisms leading to differential susceptibility of neuronal populations to stress and for designing therapeutic strategies for the treatment of PD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS075222-01
Application #
8161570
Study Section
Cellular and Molecular Biology of Neurodegeneration Study Section (CMND)
Program Officer
Sutherland, Margaret L
Project Start
2011-09-30
Project End
2016-07-31
Budget Start
2011-09-30
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$334,093
Indirect Cost
Name
Columbia University (N.Y.)
Department
Neurology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Post, Michael R; Lieberman, Ori J; Mosharov, Eugene V (2018) Can Interactions Between ?-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease? Front Neurosci 12:161
Lieberman, Ori J; McGuirt, Avery F; Mosharov, Eugene V et al. (2018) Dopamine Triggers the Maturation of Striatal Spiny Projection Neuron Excitability during a Critical Period. Neuron 99:540-554.e4
Hoffman, Benjamin U; Baba, Yoshichika; Griffith, Theanne N et al. (2018) Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses. Neuron :
Lautenschläger, Janin; Mosharov, Eugene V; Kanter, Ellen et al. (2018) An Easy-to-Implement Protocol for Preparing Postnatal Ventral Mesencephalic Cultures. Front Cell Neurosci 12:44
Fischer, Kathryn D; Houston, Alex C W; Desai, Rajeev I et al. (2018) Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl) 235:1371-1387
Caine, Charlotte; Shohat, Meytal; Kim, Jeong-Ki et al. (2017) A pathogenic S250F missense mutation results in a mouse model of mild aromatic l-amino acid decarboxylase (AADC) deficiency. Hum Mol Genet 26:4406-4415
Aguilar, Jenny I; Dunn, Matthew; Mingote, Susana et al. (2017) Neuronal Depolarization Drives Increased Dopamine Synaptic Vesicle Loading via VGLUT. Neuron 95:1074-1088.e7
Lieberman, Ori J; Choi, Se Joon; Kanter, Ellen et al. (2017) ?-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin. eNeuro 4:
Kempadoo, Kimberly A; Mosharov, Eugene V; Choi, Se Joon et al. (2016) Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory. Proc Natl Acad Sci U S A 113:14835-14840
Pereira, Daniela B; Schmitz, Yvonne; Mészáros, József et al. (2016) Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum. Nat Neurosci 19:578-86

Showing the most recent 10 out of 19 publications